These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7776826)

  • 41. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.
    Compton DR; Rice KC; De Costa BR; Razdan RK; Melvin LS; Johnson MR; Martin BR
    J Pharmacol Exp Ther; 1993 Apr; 265(1):218-26. PubMed ID: 8474008
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
    Craft RM; Wakley AA; Tsutsui KT; Laggart JD
    J Pharmacol Exp Ther; 2012 Mar; 340(3):787-800. PubMed ID: 22182934
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure-activity analysis of anandamide analogs: relationship to a cannabinoid pharmacophore.
    Thomas BF; Adams IB; Mascarella SW; Martin BR; Razdan RK
    J Med Chem; 1996 Jan; 39(2):471-9. PubMed ID: 8558515
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacological profile of delta 9-THC carbamate.
    Little PJ; Kaplan NC; Martin BR
    Alcohol Drug Res; 1987; 7(5-6):517-23. PubMed ID: 3040025
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel conformationally restricted tetracyclic analogs of delta8-tetrahydrocannabinol.
    Khanolkar AD; Lu D; Fan P; Tian X; Makriyannis A
    Bioorg Med Chem Lett; 1999 Aug; 9(15):2119-24. PubMed ID: 10465529
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and pharmacological properties of 11-hydroxy-3-(1',1'-dimethylheptyl)hexahydrocannabinol: a high-affinity cannabinoid agonist.
    Yan G; Yin D; Khanolkar AD; Compton DR; Martin BR; Makriyannis A
    J Med Chem; 1994 Aug; 37(16):2619-22. PubMed ID: 8057304
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural requirements for cannabinoid-induced antinociceptive activity in mice.
    Martin BR
    Life Sci; 1985 Apr; 36(16):1523-30. PubMed ID: 2984503
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Marihuana-like activity of new synthetic tetrahydrocannabinols.
    Martin BR; Dewey WL; Harris LS; Beckner J
    Pharmacol Biochem Behav; 1975; 3(5):849-53. PubMed ID: 1208625
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization and autoradiographic localization of the cannabinoid binding site in rat brain using [3H]11-OH-delta 9-THC-DMH.
    Thomas BF; Wei X; Martin BR
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1383-90. PubMed ID: 1335065
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.
    Varvel SA; Bridgen DT; Tao Q; Thomas BF; Martin BR; Lichtman AH
    J Pharmacol Exp Ther; 2005 Jul; 314(1):329-37. PubMed ID: 15831444
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists, and antagonists.
    Martin BR; Jefferson R; Winckler R; Wiley JL; Huffman JW; Crocker PJ; Saha B; Razdan RK
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1065-79. PubMed ID: 10454479
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and pharmacological activities in mice of halogenated delta 9-tetrahydrocannabinol derivatives.
    Usami N; Kobana K; Yoshida H; Kimura T; Watanabe K; Yoshimura H; Yamamoto I
    Chem Pharm Bull (Tokyo); 1998 Sep; 46(9):1462-7. PubMed ID: 9775440
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel 1',1'-chain substituted Delta(8)-tetrahydrocannabinols.
    Papahatjis DP; Nikas SP; Andreou T; Makriyannis A
    Bioorg Med Chem Lett; 2002 Dec; 12(24):3583-6. PubMed ID: 12443781
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interactions between THC and cannabidiol in mouse models of cannabinoid activity.
    Varvel SA; Wiley JL; Yang R; Bridgen DT; Long K; Lichtman AH; Martin BR
    Psychopharmacology (Berl); 2006 Jun; 186(2):226-34. PubMed ID: 16572263
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain.
    Adams IB; Compton DR; Martin BR
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1209-17. PubMed ID: 9495885
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cannabinoid pharmacological properties common to other centrally acting drugs.
    Wiley JL; Martin BR
    Eur J Pharmacol; 2003 Jun; 471(3):185-93. PubMed ID: 12826237
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 3-(1',1'-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor.
    Huffman JW; Liddle J; Yu S; Aung MM; Abood ME; Wiley JL; Martin BR
    Bioorg Med Chem; 1999 Dec; 7(12):2905-14. PubMed ID: 10658595
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Spinal mechanisms of delta 9-tetrahydrocannabinol-induced analgesia.
    Smith PB; Martin BR
    Brain Res; 1992 Apr; 578(1-2):8-12. PubMed ID: 1324767
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cerebellar CB(1) receptor mediation of Delta(9)-THC-induced motor incoordination and its potentiation by ethanol and modulation by the cerebellar adenosinergic A(1) receptor in the mouse.
    Dar MS
    Brain Res; 2000 May; 864(2):186-94. PubMed ID: 10802025
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacological and behavioral evaluation of alkylated anandamide analogs.
    Adams IB; Ryan W; Singer M; Razdan RK; Compton DR; Martin BR
    Life Sci; 1995; 56(23-24):2041-8. PubMed ID: 7776830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.